MedPath

EAPA-115

Generic Name
EAPA-115

Study to Evaluate the Pharmacodynamics After Single Oral Dosing of Tegoprazan, EAPA115 and RAPA115 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2020-01-18
Last Posted Date
2020-12-01
Lead Sponsor
HK inno.N Corporation
Target Recruit Count
19
Registration Number
NCT04231136
Locations
🇰🇷

Seoul National University Hospital, Clinical Trial Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath